Articles

Results 1 to 5 of 25
Most popular |Most recent


Laboratory Research Arrangements with Referral Sources Require Careful Structuring

USA - November 1 2019 Laboratory arrangements with referral sources have long been subject to scrutiny by federal regulators, and the potential penalties involved can be...

Kayla J. Cristales, Christopher Rogers.

Fiduciary Duties of Directors in Medical Technology

USA - April 24 2019 Theranos Inc., a former biotech company in Silicon Valley, and the source of significant media coverage since 2015, presents a unique case study for...

Jessica Berkowitz, Maria V. Hopper, Eric S. Williams.

2018 Year in Review - The False Claims Act

USA - January 16 2019 The False Claims Act, 31 U.S.C. 3729 et seq. (FCA), continued to be a significant focus of government and whistleblower activity in 2018. This Year...

Phillip L. Kim, Neil Issar, Bill Morrison, Nicole Somerville, Stacy Brainin, Andrew Guthrie, Christopher Rogers, Taryn McDonald.

Differences and Similarities Between - Federal Anti-Kickback Statute and the 2018 Eliminating Kickbacks in Recovery Act

USA - December 31 2018 The Eliminating Kickbacks in Recovery Act of 2018 (“EKRA”) marks a significant shift in federal oversight of the healthcare industry, applying the...

Kayla Johnson, Christopher Rogers.

Healthcare Hazards Involving Medical Records During Bankruptcy

USA - May 8 2018 Companies in the healthcare industry face many unique challenges when undergoing a bankruptcy, including challenges arising due to the federal and...

C.J. Donald, Kenya S. Woodruff.